share_log

华阳智能(301502.SZ):核心产品电子注射笔已在生长激素等领域成熟应用

Huayang Asia Vets (301502.SZ): Core product electronic injection pens have been maturely applied in areas such as growth hormone.

Gelonghui Finance ·  Nov 20, 2024 01:10

Gelonghui, November 20th, Huayang Asia Vets (301502.SZ) stated in recent investor relations activities that, first of all, the company's product functionality, user experience, etc. are basically no different from foreign-funded enterprises. Compared to foreign companies, the company has advantages in terms of development cost, development time cycle, and customer customization. Secondly, foreign-funded enterprises mainly use mechanical injection pens for mass market applications, while the company's core product electronic injection pen has been maturely applied in the field of growth hormone, providing customers with more choices.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment